drugset

drugset / Trial / NCT00000187

Ritanserin in Treatment of Cocaine Dependence - 1

NCT00000187 ↗

Phase 2 Completed 80 enrolled University of Pennsylvania National Institute on Drug Abuse (NIDA) · collab

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to assess ritanserin as a pharmacotherapy for cocaine dependence.

Timeline

Start: 1992-07
Primary completion: 1994-06
Completion: —

Publications

Background Cornish JW, Maany I, Fudala PJ, Ehrman RN, Robbins SJ, O'Brien CP. A randomized, double-blind, placebo-controlled study of ritanserin pharmacotherapy for cocaine dependence. Drug Alcohol Depend. 2001 Jan 1;61(2):183-9. doi: 10.1016/s0376-8716(00)00140-x.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ritanserin	Small molecule	—	—

Indications